Monday, June 20th, 2016 - RnR Market Research

The global clinical microbiology market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to factors such as technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches.

Complete report on Clinical Microbiology Market spread across 176 Pages, Profiling 10 Companies and Supported with 74 Tables and 62 Figures is now available at http://www.rnrmarketresearch.com/microbiology-testingclinical-microbiology-market-by-product-instrument-analyzer-incubator-kit-microscope-molecular-diagnostics-clinical-application-periodontal-disease-respiratory-diseases-market-report.html .

Geographically, the clinical microbiology market is classified into four regions— North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe are mature markets for clinical microbiology products. However, emerging regions such as Asia-Pacific (including Japan, China, and India, among others) are expected to become new revenue-generating pockets in the market in the next five years. The North American market is expected to hold the largest share of the global market in 2016.

In this report, the global clinical microbiology market is segmented on the basis of product into instruments [laboratory instruments (incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, anaerobic culture systems, petridish fillers, blood culture systems, microbial culture systems, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, microscopes, and mass spectrometers)] and reagents (pathogen specific kits and general reagents).

Product development and commercialization and was the key growth strategy adopted by prominent players to strengthen their global positioning in the clinical microbiology market.

Moreover, strategies such as agreements, collaborations, and partnerships, acquisitions, and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global market during 2012–2015.

 

Interested in this New Research Study the Sample Copy of this research is Available Now

http://www.rnrmarketresearch.com/contacts/request-sample?rname=259270 .

 

New clinical study report is useful for following audience

  • Microbiological Testing/Clinical Microbiology product manufacturers
  • Healthcare service providers (Including hospitals and diagnostic centers)
  • Pharmaceutical product manufacturing companies
  • Clinical testing laboratories
  • Clinical Research Organizations (CROs)
  • Food and beverages manufacturing companies
  • Petrochemical and biofuel product manufacturing companies
  • Oil & gas producing and distribution companies
  • Gas operators, distributors, and regulators
  • Environmental monitoring committees
  • Environmental monitoring product manufacturing companies
  • Research laboratories and academic institutes
  • Market research and consulting firms

Leading players in the clinical microbiology market include bioMerieux S.A. (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.

 

Click now for more Details, Quiries, Other Information and Order this study “Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021” report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=259270 .

 

The respiratory diseases segment is expected to account for the largest share of the global market in 2016. This segment is also projected to grow fastest in the global market during 2016–2021. The significant growth potential offered by the respiratory disease segment can be attributed to factors such as the large patient population for respiratory diseases and rising prevalence of tuberculosis across developing countries

Contact Profile

RnR Market Research


About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed


Ritesh Tiwari
P: + 1 888 391 5441
W: www.rnrmarketresearch.com/

Keywords

Clinical Microbiology Market, Clinical Microbiology Research, clinical microbiology journals, Pharmaceutical, Clinical Application, Respiratory Diseases, Microbiology Testing Industry

Categories

Newsrooms

Sharing

More Formats